Depression Drugs Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Depression Drugs Market
Depression Drugs Market: By Medication Class (Monoamine Oxidase Inhibitors (MAOIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRI), Anticonvulsants, Beta-Blockers, Benzodiazepines, Others); By Brand (Celexa, Zoloft, Cymbalta, Prozac, Paxil, Others) - Forecast(2018 - 2023)
Report Code : HCR 0242
Updated Date: 16 May, 2018  

1. Depression Drugs Market Overview
2. Executive Summary
3. Depression Drugs - Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Depression Drugs - Market Forces
   4.1. Market Drivers
      4.1.1. Rising Awareness about Different Types of Depression
      4.1.2. Rising Geriatric Population
      4.1.3. Increasing Incidences of Depression
   4.2. Market Constraints
      4.2.1. Stringent Regulations for the Approval of Antidepressants
      4.2.2. Strict Regulations for the Commercial Usage of Antidepressants without prescription
      4.2.3.    Patent Expiry of Several Blockbuster Antidepressant Drugs
   4.3. Market Challenges
      4.3.1. Narrow Drug Pipelines
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Depression Drugs Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
6. Depression Drugs Market – By Medication Class
   6.1. Monoamine Oxidase Inhibitors (MAOIs)
   6.2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
   6.3. Anticonvulsants
   6.4. Beta-Blockers
   6.5. Tetracyclic Antidepressants (TeCAs)
   6.6. Benzodiazepines
   6.7. Selective Serotonin Reuptake Inhibitors (SSRIs)         
7. Depression Drugs Market – By Brand
   7.1. Celexa
   7.2. Zoloft
   7.3. Cymbalta
   7.4. Prozac
   7.5. Paxil
   7.6. Lexapro
   7.7. Prestiq
   7.8. Others
8. Depression Drugs Market - Geographical Analysis
   8.1. Introduction
   8.2. North America
      8.2.1. USA
      8.2.2. Mexico
      8.2.3. Canada
   8.3. Europe
      8.3.1. Germany
      8.3.2. France
      8.3.3. U.K.
      8.3.4. Italy
      8.3.5. Spain
      8.3.6. Rest of Europe
   8.4. APAC
      8.4.1. China
      8.4.2. India
      8.4.3. Japan
      8.4.4. Australia
      8.4.5. Rest of APAC
   8.5. Rest of the World (RoW)
9. Market Entropy
   9.1. New Product Launches
   9.2. Mergers and Acquisitions,
   9.3. Collaborations, JVs and Partnerships
10. Company Profiles (Overview, Financials, SWOT Analysis – Top 05 Companies, Developments and Product Portfolio)
   10.1. Novartis International AG
   10.2. Janssen Pharmaceuticals, Inc.
   10.3. Lupin Pharmaceuticals, Inc.
   10.4. Abbott Laboratories
   10.5. Allergan, Plc
   10.6. MSI Methylation Sciences Inc.
   10.7. Luye Pharma Group Ltd.
   10.8. H. Lundbeck A/S
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll